SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-008890
Filing Date
2023-03-24
Accepted
2023-03-24 16:30:19
Documents
16
Period of Report
2023-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54985
2 form8-k_001.jpg GRAPHIC 2206
3 ex10-1.htm EX-10.1 174420
4 ex10-2.htm EX-10.2 33885
5 ex99-1.htm EX-99.1 79282
  Complete submission text file 0001493152-23-008890.txt   566355

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ngvt-20230320.xsd EX-101.SCH 3227
7 XBRL LABEL FILE ngvt-20230320_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ngvt-20230320_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3528
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

IRS No.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 23760226
SIC: 2800 Chemicals & Allied Products